On Oct. 5, 2014, BD and CareFusion announced a definitive agreement whereby BD acquired CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to create a global leader in medication management and patient safety solutions.

Under the terms of the transaction, CareFusion shareholders received $49.00 in cash and 0.0777 of a share of BD for each share of CareFusion, or a total of $58.00 per CareFusion share based on BDﾒs closing price as of Oct. 3, 2014.